APA (7th ed.) Citation

Digiacomo, G., Fumarola, C., Monica, S. L., Bonelli, M., Cavazzoni, A., Galetti, M., . . . Petronini, P. G. (2022, July). CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells. Frontiers in Oncology.

Chicago Style (17th ed.) Citation

Digiacomo, Graziana, et al. "CDK4/6 Inhibitors Improve the Anti-tumor Efficacy of Lenvatinib in Hepatocarcinoma Cells." Frontiers in Oncology Jul. 2022.

MLA (9th ed.) Citation

Digiacomo, Graziana, et al. "CDK4/6 Inhibitors Improve the Anti-tumor Efficacy of Lenvatinib in Hepatocarcinoma Cells." Frontiers in Oncology, Jul. 2022.